Second quarter impacted by declines in glyphosate business

Group sales fall by 8.2 percent (Fx & portfolio adj.) to 11.044 billion euros

10-Aug-2023 - Bayer published detailed results for the second quarter of 2023, after having already communicated key figures for the three-month period and lowering its outlook for full-year 2023. The revised guidance was mainly due to a significant further decline in sales of glyphosate-based products at the ...

Bayer lowers full-year outlook

25-Jul-2023 - The Bayer Group adjusted its full-year outlook for 2023 downward on Monday, mainly due to a significant further decline in sales of glyphosate-based products. For full-year 2023, Bayer now anticipates sales of between 48.5 billion and 49.5 billion euros on a currency-adjusted basis, i.e. based on ...

Bayer: Slow start to the year as expected

Bayer Group business performance in the first quarter of 2023

11-May-2023 - The Bayer Group experienced a slow start to 2023 as expected. “Sales were on a par with the exceptionally strong prior-year quarter,” CEO Werner Baumann said on Thursday when presenting the Quarterly Statement for the first quarter. The normalization in the glyphosate business has accelerated, ...

Bayer: Significant growth in sales and earnings

Exceptionally strong performance at Crop Science

28-Feb-2023 - The Bayer Group achieved strong growth last year, posting significantly higher sales and earnings. “2022 was a very successful year for Bayer despite the challenging environment. We were able to deliver, even during these difficult times, and met the upgraded financial targets we set in August,” ...

Bill Anderson to become CEO of Bayer AG

09-Feb-2023 - The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werner ...

Bayer with continued strong performance

Crop Science achieves strong sales gains – sales also up at Pharmaceuticals and Consumer Health

08-Nov-2022 - The Bayer Group maintained its strong business performance across all three divisions in the third quarter. “Despite rising inflation and global supply chain problems, we were again able to boost sales and earnings,” said Werner Baumann, Chairman of the Board of Management, when presenting the ...

Bayer: Very good start to the year – strong sales and earnings growth

Outlook for 2022 confirmed – confident about the full year despite uncertainty due to global crises

10-May-2022 - The Bayer Group had a very successful start to 2022. “We achieved outstanding sales and earnings growth, with particularly substantial gains for our agriculture business,” said Werner Baumann, Chairman of the Board of Management, on Tuesday as he presented the quarterly statement for the first ...

Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollars

10-Mar-2022 - Bayer and Cinven have entered into a definitive agreement regarding the sale of Bayer’s Environmental Science Professional business for a purchase price of 2.6 billion U.S. dollars (2.4 billion euros), Bayer announced on Thursday. “This divestment represents a very attractive purchase price and ...

Bayer: Dynamic growth

Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros

01-Mar-2022 - The Bayer Group had a successful year in 2021, both operationally and strategically. “We posted substantial growth, strengthened our innovation pipeline and made progress toward our sustainability targets. All this shows that Bayer is on the right track!” said Werner Baumann, Chairman of the ...

Bayer grows sales and earnings significantly

Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros

09-Nov-2021 - The Bayer Group registered a significant increase in sales and earnings in the third quarter of 2021. “We delivered strong operational performance, with all divisions showing strong growth momentum,” said Werner Baumann, Chairman of the Board of Management, on Tuesday when presenting the ...